These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16355016)

  • 1. The cardiometabolic syndrome as a cardiovascular risk factor.
    Govindarajan G; Whaley-Connell A; Mugo M; Stump C; Sowers JR
    Am J Med Sci; 2005 Dec; 330(6):311-8. PubMed ID: 16355016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
    Whaley-Connell A; Johnson MS; Sowers JR
    Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidaemia, hypercoagulability and the metabolic syndrome.
    Kakafika AI; Liberopoulos EN; Karagiannis A; Athyros VG; Mikhailidis DP
    Curr Vasc Pharmacol; 2006 Jul; 4(3):175-83. PubMed ID: 16842135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and insulin resistance as risk factors for chronic kidney disease.
    Whaley-Connell A; Pavey BS; Afroze A; Bakris GL
    J Cardiometab Syndr; 2006; 1(3):209-14; quiz 215-6. PubMed ID: 17679819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between hyperinsulinemia, hypertension and progressive renal disease.
    El-Atat FA; Stas SN; McFarlane SI; Sowers JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2816-27. PubMed ID: 15504934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic syndrome: pathophysiology and treatment.
    Castro JP; El-Atat FA; McFarlane SI; Aneja A; Sowers JR
    Curr Hypertens Rep; 2003 Oct; 5(5):393-401. PubMed ID: 12948432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review.
    Nakashima A; Kato K; Ohkido I; Yokoo T
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and the metabolic syndrome.
    Lann D; Gallagher E; Leroith D
    Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease.
    Mao X; Ait-Aissa K; Lagrange J; Youcef G; Louis H
    Biomed Mater Eng; 2012; 22(1-3):35-48. PubMed ID: 22766701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Resistance and β-Cell Dysfunction in Relation to Cardiometabolic Risk Patterns.
    Wang T; Zhao Z; Xu Y; Qi L; Xu M; Lu J; Li M; Chen Y; Dai M; Zhao W; Ning G; Wang W; Bi Y
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2207-2215. PubMed ID: 29590437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic syndrome and chronic kidney disease.
    Lastra G; Manrique C; McFarlane SI; Sowers JR
    Curr Diab Rep; 2006 Jun; 6(3):207-12. PubMed ID: 16898573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: organ involvement in the cardiometabolic syndrome.
    Hayden MR; Stump CS; Sowers JR
    J Cardiometab Syndr; 2006; 1(1):16-24. PubMed ID: 17675904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NF-kB activation as a molecular basis of pathological process by metabolic syndrome].
    Kaĭdashev IP
    Fiziol Zh (1994); 2012; 58(1):93-101. PubMed ID: 22590744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and the metabolic syndrome.
    Morse SA; Zhang R; Thakur V; Reisin E
    Am J Med Sci; 2005 Dec; 330(6):303-10. PubMed ID: 16355015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications.
    Domingueti CP; Dusse LM; Carvalho Md; de Sousa LP; Gomes KB; Fernandes AP
    J Diabetes Complications; 2016; 30(4):738-45. PubMed ID: 26781070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.